🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Neuropathic Characteristics of Subacromial Pain Syndrome

Recruitingn/aAges 19 Years - anyAllIzmir City Hospital
NCT07057128 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This single-center observational study aims to investigate neuropathic pain descriptors and their relationship with central sensitization in patients diagnosed with subacromial pain syndrome (SAPS) who have had shoulder pain for at least 3 months. A total of 82 participants aged 19 years or older will be recruited from the Physical Medicine and Rehabilitation outpatient clinic of Izmir City Hospital. After obtaining informed consent, participants will complete validated questionnaires assessing pain severity (VAS), neuropathic pain characteristics (painDETECT), central sensitization (Central Sensitization Inventory), and shoulder function (SPADI). Range of motion will be measured using a goniometer. No imaging or invasive procedures will be performed. Using the central sensitization scale and pain detect, the presence or absence of the 7 pain descriptors will be investigated in patients

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Clinical diagnosis of subacromial pain syndrome (SAPS) 2. Age ≥ 19 years 3. Shoulder pain lasting for at least 3 months 4. Shoulder pain intensity rated as 3 or higher on the Visual Analog Scale (VAS) in the past week 5. Positive findings on the following clinical tests: Hawkins-Kennedy test Painful arc test Infraspinatus muscle strength test Exclusion Criteria: 1. History of inflammatory disease involving the shoulder joint 2. History of neurological disorders 3. History of prior shoulder surgery 4. Positive drop arm test 5. Loss of passive range of motion in the shoulder joint 6. Presence of muscle strength loss 7. Structurally confirmed shoulder pathology based on imaging studies 8. Full-thickness tear of the rotator cuff muscles 9. Presence of neurodeficit in the upper extremity 10. Diagnosis of cancer or active infection 11. Use of medications for neuropathic pain within the past 3 months for any reason
💊

What it tests

  • Not listed
📍

Where

1 site
İzmir City Hospital
Izmir, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy